Factlen ExplainerACA PremiumsExplainerJul 16, 2026, 8:24 AM· 5 min read· #2 of 2 in health

Why ACA Marketplace Premiums Are Proposed to Rise 14% in 2026

Health insurers are proposing double-digit premium increases for the second consecutive year, driven by expiring federal subsidies, rising drug costs, and increased medical utilization.

By Factlen Editorial Team

Consumer Advocates 45%Insurers and Actuaries 35%Fiscal Conservatives 20%
Consumer Advocates
Focus on the devastating impact the expiration of enhanced subsidies will have on household budgets, urging immediate congressional action.
Insurers and Actuaries
Argue that rate hikes are a mathematical necessity driven by the soaring cost of care, hospital consolidation, and expensive new drugs.
Fiscal Conservatives
Highlight the massive federal deficit impact of the enhanced subsidies, arguing that the ACA market needs structural reform rather than perpetual federal bailouts.

What's not represented

  • · Small business owners navigating the individual market
  • · Healthcare providers negotiating reimbursement rates

Why this matters

For the millions of Americans who buy their own health insurance, understanding the mechanics behind the 2026 rate hikes is critical for navigating open enrollment. Knowing how the expiration of enhanced subsidies interacts with benchmark plan pricing can empower households to shop around and avoid absorbing the full cost increase.

Key points

  • Insurers are proposing an average 14% rate hike for 2026 ACA marketplace plans.
  • The expiration of enhanced federal subsidies at the end of 2025 is a major driver of consumer cost anxiety.
  • Medical inflation and the rising utilization of expensive specialty drugs are pushing underlying care costs higher.
  • Consumers are strongly advised to actively shop during open enrollment rather than auto-renewing their current plans.
14%
Average proposed premium increase for 2026
8.5%
Income cap for premiums under enhanced subsidies
400%
Federal Poverty Level threshold for the subsidy cliff

For the second consecutive year, health insurers participating in the Affordable Care Act (ACA) marketplaces are proposing double-digit premium increases. Early filings for the 2026 plan year indicate an average proposed hike of 14%, a figure that has triggered sticker shock among consumer advocates and policy analysts alike. However, the headline number only tells a fraction of the story. The proposed increases are the result of a complex collision between expiring federal legislation, shifting medical economics, and a post-pandemic surge in healthcare utilization.[3]

To understand the 2026 landscape, it is necessary to look at the artificial price suppression of the past five years. During the pandemic, the American Rescue Plan Act introduced enhanced Premium Tax Credits (PTCs), which were later extended through the end of 2025 by the Inflation Reduction Act. These enhanced subsidies fundamentally altered the math of the individual market, capping consumer premium contributions at 8.5% of their household income and drawing record enrollment numbers.[1]

The most significant driver of the 2026 premium anxiety is the looming expiration of these enhanced subsidies. Without congressional intervention before the end of the year, the ACA subsidy structure will revert to its original, less generous formula. This means the federal government will absorb less of the premium cost, shifting the financial burden directly back onto the consumer. For many enrollees, the loss of the subsidy will feel like a price hike, even before the actual insurance rate increases are factored in.[1][2]

Proposed premium increases have hit double digits for the second consecutive year.
Proposed premium increases have hit double digits for the second consecutive year.

The expiration also threatens to resurrect the dreaded "subsidy cliff." Under the enhanced structure, individuals earning more than 400% of the Federal Poverty Level were still eligible for subsidies if their premiums exceeded 8.5% of their income. If the enhancements expire, anyone earning even one dollar over that 400% threshold will abruptly lose all federal premium assistance, exposing them to the full, unsubsidized cost of the 14% rate hikes.[2]

Beyond the shifting subsidy landscape, insurers are grappling with severe medical inflation. Hospitals and healthcare providers, squeezed by their own rising labor costs and supply chain expenses, have successfully negotiated higher reimbursement rates from insurance carriers. When a hospital charges an insurer more for a routine procedure, the insurer passes that cost directly into the premium base for the following year.[3]

Prescription drug costs are also playing an outsized role in the 2026 actuarial models. The explosion in utilization of highly effective, but highly expensive, GLP-1 receptor agonists for diabetes and weight management has introduced a massive new cost center for health plans. As more patients qualify for and demand these medications, insurers are forced to raise premiums across the entire risk pool to cover the aggregate expense.[2][3]

If enhanced federal subsidies expire, the 'subsidy cliff' will return for households earning over 400% of the poverty level.
If enhanced federal subsidies expire, the 'subsidy cliff' will return for households earning over 400% of the poverty level.
Prescription drug costs are also playing an outsized role in the 2026 actuarial models.

Furthermore, general healthcare utilization has rebounded and stabilized at a higher baseline than pre-pandemic levels. Patients are no longer deferring elective surgeries, routine screenings, or chronic disease management. While this is a positive indicator for public health, the increased volume of medical claims directly translates to higher anticipated costs for insurers, which they are legally required to project and price into their upcoming premiums.

It is important to note that insurers cannot simply raise rates to pad their profit margins. The ACA enforces a Medical Loss Ratio (MLR) rule, which requires carriers to spend at least 80% of premium dollars on actual medical care and quality improvement. If an insurer overprices its premiums and fails to hit that 80% threshold, it must issue rebate checks to its enrollees. Therefore, proposed rate hikes are generally a highly regulated reflection of actual anticipated medical costs.[3]

For consumers, navigating the 2026 open enrollment period will require a strategic understanding of the "benchmark plan." Federal subsidies are calculated based on the cost of the second-lowest-cost silver plan in a specific geographic rating area. If a new, cheaper plan enters the market and becomes the benchmark, the total subsidy amount available to everyone in that area decreases, regardless of which plan they are actually enrolled in.[2]

Rising hospital costs and the explosion of specialty drug utilization are driving the underlying cost of care.
Rising hospital costs and the explosion of specialty drug utilization are driving the underlying cost of care.

This dynamic makes passive auto-renewal highly risky for 2026. A consumer who allows their current plan to auto-renew might find that their plan's premium increased by 14%, while their federal subsidy decreased because the benchmark plan shifted. The combined effect could result in a massive spike in their monthly out-of-pocket premium.[3]

To blunt the impact of these hikes, several states are leaning heavily into Section 1332 waivers to establish or expand state-level reinsurance programs. These programs use a mix of state and federal funds to pay for the highest-cost medical claims, effectively removing the most expensive patients from the standard risk pool. By capping the insurers' exposure to catastrophic claims, states can artificially lower the baseline premiums for everyone else.[2]

The ultimate fate of the 2026 premiums now rests largely in the hands of Congress. The expiration of the enhanced subsidies presents a massive political vulnerability, and lawmakers face intense pressure to pass an extension during the lame-duck session or retroactively in early 2026. However, extending the subsidies carries a substantial federal price tag, setting the stage for a fierce fiscal debate.[1][3]

Active shopping is critical to avoiding the full brunt of the proposed rate hikes.
Active shopping is critical to avoiding the full brunt of the proposed rate hikes.

Until the legislative dust settles, consumers must prepare for a volatile open enrollment season. The 14% proposed increase is an average; actual rate changes will vary wildly by state, county, and individual carrier. Some regions with robust competition may see single-digit increases, while consolidated markets could face hikes exceeding 20%.[3]

The most empowering action a consumer can take is to actively shop the marketplace. By updating their income projections, evaluating new market entrants, and understanding how their local benchmark plan has shifted, enrollees can often find alternative coverage that mitigates the worst of the rate hikes. In a year defined by premium turbulence, active engagement is the only reliable shield.[2][3]

How we got here

  1. March 2021

    The American Rescue Plan Act introduces enhanced Premium Tax Credits, eliminating the subsidy cliff.

  2. August 2022

    The Inflation Reduction Act extends the enhanced ACA subsidies through the end of 2025.

  3. July 2026

    Insurers file proposed rates for the 2026 plan year, averaging a 14% increase.

  4. December 2026

    Deadline for Congress to extend the enhanced subsidies before the 2026 plan year begins.

Viewpoints in depth

Health Insurers' View

Carriers argue that rate hikes are a direct, regulated reflection of the soaring cost of delivering medical care.

Insurance carriers and actuaries point out that their pricing models are strictly bound by the Medical Loss Ratio, meaning they cannot arbitrarily raise rates to increase profits. They point to the aggressive consolidation of hospital systems, which gives providers massive leverage to demand higher reimbursement rates. Furthermore, insurers highlight the unprecedented demand for expensive GLP-1 weight-loss drugs and a post-pandemic surge in elective procedures as unavoidable costs that must be distributed across the risk pool.

Consumer Advocates' View

Advocates warn that the combination of rate hikes and expiring subsidies will price millions out of the market.

Organizations tracking healthcare affordability argue that the 14% rate hike is only half the crisis. Their primary concern is the expiration of the enhanced Premium Tax Credits. They warn that if the 'subsidy cliff' returns, middle-income families will face an impossible financial burden, potentially leading to a massive spike in the uninsured rate. These advocates are heavily lobbying Congress to make the enhanced subsidies permanent, arguing that healthcare access should not be subject to year-to-year legislative brinkmanship.

Fiscal Policy Analysts' View

Analysts caution against the long-term deficit impact of permanently subsidizing a fundamentally expensive healthcare system.

Fiscal conservatives and budget analysts from organizations like the Congressional Budget Office highlight the massive price tag attached to the enhanced subsidies. They argue that continually increasing federal subsidies simply masks the underlying problem of out-of-control medical inflation, effectively writing a blank check to hospitals and pharmaceutical companies. From this perspective, the focus should shift away from subsidizing premiums and toward structural reforms that lower the actual cost of delivering care.

What we don't know

  • Whether Congress will pass an extension of the enhanced Premium Tax Credits during the lame-duck session.
  • How state insurance regulators will modify or reject the proposed 14% rate hikes before they are finalized.
  • Exactly how many consumers will actively switch plans versus allowing their coverage to auto-renew at higher rates.

Key terms

Premium Tax Credit (PTC)
A refundable tax credit designed to help eligible individuals and families with low or moderate income afford health insurance purchased through the Health Insurance Marketplace.
Subsidy Cliff
A threshold in the original ACA law where individuals earning even one dollar over 400% of the Federal Poverty Level abruptly lost all eligibility for premium subsidies.
Benchmark Plan
The second-lowest-cost silver plan available in a specific geographic area, which the federal government uses to calculate the baseline amount of subsidy a consumer receives.
Medical Loss Ratio (MLR)
An ACA rule requiring health insurance companies to spend at least 80% of the premium dollars they collect on actual medical care and quality improvement, rather than administrative costs or profits.

Frequently asked

Why are ACA premiums going up by 14%?

The proposed increases are driven by a combination of medical inflation (hospitals charging more), the rising cost of prescription drugs like GLP-1s, and a general increase in patients seeking medical care.

What happens if the enhanced subsidies expire?

If Congress does not extend the enhanced subsidies by the end of 2025, the federal government will cover less of the premium cost, and the 'subsidy cliff' will return, drastically raising out-of-pocket costs for middle-income earners.

Will my specific premium go up exactly 14%?

Not necessarily. The 14% is a national average of proposed rates. Your actual premium change will depend on your state, your specific insurance carrier, and how your local 'benchmark plan' changes.

How can I avoid the premium increase?

The most effective strategy is to actively shop the marketplace during open enrollment. Because subsidies are tied to the second-lowest-cost silver plan, switching to a new plan can often offset the rate hikes.

Sources

Source coverage

3 outlets

3 viewpoints surfaced

Consumer Advocates 45%Insurers and Actuaries 35%Fiscal Conservatives 20%
  1. [1]Congressional Budget OfficeFiscal Conservatives

    Federal Subsidies for Health Insurance Coverage: 2026 to 2036

    Read on Congressional Budget Office
  2. [2]Health AffairsConsumer Advocates

    The Return of the Subsidy Cliff: What Expiration Means for the Individual Market

    Read on Health Affairs
  3. [3]Factlen Editorial TeamConsumer Advocates

    Synthesis by Factlen editorial team

    Read on Factlen Editorial Team
Stay informed

Every angle. Every day.

Get health stories with full source coverage and perspective breakdowns delivered to your inbox.